Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 3/2004

Ausgabe 3/2004

Inhaltsverzeichnis ( 18 Artikel )

01.03.2004 | Review | Ausgabe 3/2004

A primer on cancer immunology and immunotherapy

Michael T. Lotze, Michael Papamichail

01.03.2004 | Review | Ausgabe 3/2004

Identification of tumour antigens by serological analysis of cDNA expression cloning

Geng Li, Amanda Miles, Aija Line, Robert C Rees

01.03.2004 | Review | Ausgabe 3/2004

Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning

Dirk Jäger, Christian Taverna, Alfred Zippelius, Alexander Knuth

01.03.2004 | Review | Ausgabe 3/2004

Tetraspanins connect several types of Ig proteins: IgM is a novel component of the tetraspanin web on B-lymphoid cells

François Le Naour, Stéphanie Charrin, Valérie Labas, Jean-Pierre Le Caer, Claude Boucheix, Eric Rubinstein

01.03.2004 | Review | Ausgabe 3/2004

Apoptosis pathways in cancer and cancer therapy

Klaus-Michael Debatin

01.03.2004 | Review | Ausgabe 3/2004

The use of gene function to identify the rate-limiting steps controlling cell fate

Gwyn T. Williams, Farzin Farzaneh

01.03.2004 | Review | Ausgabe 3/2004

Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy

Constantin N. Baxevanis, Panagiota A. Sotiropoulou, Nectaria N. Sotiriadou, Michael Papamichail

01.03.2004 | Review | Ausgabe 3/2004

Natural killer lymphocytes: biology, development, and function

Michael Papamichail, Sonia A. Perez, Angelos D. Gritzapis, Constantin N. Baxevanis

01.03.2004 | Review | Ausgabe 3/2004

The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy

Harpreet Singh-Jasuja, Niels P. N. Emmerich, Hans-Georg Rammensee

01.03.2004 | Review | Ausgabe 3/2004

Identification of tumor antigens and T-cell epitopes, and its clinical application

Annette Paschen, Stefan Eichmuller, Dirk Schadendorf

01.03.2004 | Review | Ausgabe 3/2004

Immunological inhibition of carcinogenesis

Michela Spadaro, Stefania Lanzardo, Claudia Curcio, Guido Forni, Federica Cavallo

01.03.2004 | Review | Ausgabe 3/2004

Recombinant immunotoxins and retargeted killer cells: employing engineered antibody fragments for tumor-specific targeting of cytotoxic effectors

Winfried Wels, Markus Biburger, Tina Müller, Benjamin Dälken, Ulrike Giesübel, Torsten Tonn, Christoph Uherek

01.03.2004 | Review | Ausgabe 3/2004

Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer

Chiara Castelli, Licia Rivoltini, Francesca Rini, Filiberto Belli, Alessandro Testori, Michele Maio, Vincenzo Mazzaferro, Jorgelina Coppa, Pramod K. Srivastava, Giorgio Parmiani

01.03.2004 | Review | Ausgabe 3/2004

Exosome-based immunotherapy

Nathalie Chaput, Julien Taïeb, Noël E. C. Schartz, Fabrice André, Eric Angevin, Laurence Zitvogel

01.03.2004 | Review | Ausgabe 3/2004

Dendritic cell biology and cancer therapy

Theresa L. Whiteside, Christine Odoux

01.03.2004 | Review | Ausgabe 3/2004

Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination

Pedro Romero, Jean-Charles Cerottini, Daniel E. Speiser

01.03.2004 | Review | Ausgabe 3/2004

Identifying biomarkers and surrogates of tumors (cancer biometrics): correlation with immunotherapies and immune cells

Michael T. Lotze, Robert C. Rees

01.03.2004 | Review | Ausgabe 3/2004

Tumour escape: antitumour effectors too much of a good thing?

Graham Pawelec

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise